Navigation Links
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
Date:12/4/2009

WILMINGTON, Del., Dec. 4 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as adjunctive (add-on) treatment to antidepressants in adults with Major Depressive Disorder (MDD). SEROQUEL XR is the only medication in its class approved by the FDA to treat both major depressive disorder as adjunctive therapy and acute depressive episodes associated with bipolar disorder as monotherapy.(1)(2)

MDD affects approximately 14.2 million American adults in a given year, and today it is often treated with antidepressants(3).( )Selective serotonin reuptake inhibitors, or SSRIs, are among the most commonly prescribed class of antidepressant medications for depression; however, in many cases patients fail to respond adequately to treatment(4). Results from a National Institute of Mental Health study, STAR*D, showed that approximately 63% of patients did not achieve remission with the SSRI citalopram when used as a first-line treatment(4). Additionally, this study reported that overall approximately one-third of patients with MDD failed to achieve study defined remission(4). This approval for SEROQUEL XR provides physicians with a new adjunctive treatment option for patients with MDD who have an inadequate response to their current antidepressant.

In addition to the FDA approval for the adjunctive indication in MDD, AstraZeneca has received a Complete Response Letter (CRL) from the FDA asking for additional information for the sNDAs for SEROQUEL XR as acute monotherapy and maintenance monotherapy for the treatment of MDD in adult patients.

AstraZeneca is evaluating the contents of the CRL. AstraZeneca will continue discussions with the FDA and will provide a response to the ag
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
2. FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
4. FDA Approves Agriflu Seasonal Influenza Vaccine
5. FDA Approves Lysteda to Treat Heavy Menstrual Bleeding
6. Rogan-Delft Approves Matrox Xenia Series for Use With Zillion Suite
7. FDA approves GlaxoSmithKlines VOTRIENT(TM) for advanced renal cell cancer
8. FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
9. FDA Approves New Treatment for Advanced Form of Kidney Cancer
10. FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
11. FDA Approves Cervarix, GlaxoSmithKlines Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014 Yesterday, former ... (Moberg) medical device manufacturing facility. Rep. Kennedy and ... neurological monitors facilitate cutting-edge research in neurological disease ... and mental health advocate, Garen Staglin , ... to fostering fundamental changes that will radically accelerate ...
(Date:7/10/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... the sale to Galderma of all rights to Restylane, ... Valeant for $1.4 billion in cash, pursuant to the ... its acquisition of Galderma. "We are ... a company that is firmly committed to the aesthetic ...
(Date:7/10/2014)... , July 10, 2014  Decision Resources Group ... infectious disease (ID) specialists are willing to prescribe ... (oritavancin) for use as OPAT, approximately two-thirds of ... agents to their hospital inpatients. However, our findings ... patients are initiated on OPAT following hospital discharge, ...
Breaking Medicine Technology:Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... Chronic Hepatitis B e-Antigen,(HBeAg)-Negative Patients Achieved Undetectable ... N.J., April 13, 2007 /PRNewswire-FirstCall/ --,Bristol-Myers Squibb ... of,nucleoside-naive HBeAg-negative chronic hepatitis B patients,(ETV-027/901, n=99). ... levels of hepatitis B virus in the ...
... found to dramatically reduce the risk of ... tumors,(GIST), EAST HANOVER, N.J., April 12, 2007 ... mesylate)* tablets to,patients receiving placebo in a ... analysis showed participants with Kit-positive,gastrointestinal stromal tumors ...
Cached Medicine Technology:Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 2Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 3Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 4Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 5Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 2Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 3Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 4Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 5Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 6Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 7
(Date:7/13/2014)... July 13, 2014 If Dr. Lawrence Power ... has just launched at http://www.HealthYourself101.com will expand people’s ... , Power has set out to provide a health ... that’s actually – dare we say it? – entertaining to ... Power, “aims to engage the remote learner – the solitary ...
(Date:7/13/2014)... 13, 2014 According to the Living ... is a comprehensive guide that features a series of ... KP (keratosis pilaris). This guide consists of 14 ... Keratosis Pilaris? ,     Chapter 2: What Cause KP? ... I Have KP? ,     Chapter 4: Keratosis Pilaris ...
(Date:7/12/2014)... 2014 According to the new market ... Airborne Systems, and Naval Systems) - Global Forecasts and ... and Surveillance Radar market are estimated to be $6.08 ... CAGR of 5.97% to reach $8.61 billion by 2020. ... 47 figures spread through 161 pages and in-depth TOC ...
(Date:7/12/2014)... July 13, 2014 Recently, iFitDress.com, one of ... selection of red evening gowns . What’s more, all ... 56% off. , The company’s senior spokesman states, “We are ... on our website is an enjoyable shopping experience. In addition ... our online store, low prices do not always mean bad ...
(Date:7/12/2014)... July 12, 2014 The Passenger Information ... in 2013 to $20,341.36 million by 2019, at an ... and 2019. , The public transport infrastructure in North ... also available in almost every corner of the region. ... interest of public transport service providers are driving the ...
Breaking Medicine News(10 mins):Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 3Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 4Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Discounted Red Evening Gown Announced by iFitDress.com 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 4
... suggests threat of starvation triggers the switch , , THURSDAY, ... the body,s biological clock, which regulates sleep cycles based ... be overridden in extreme situations by an internal "food ... mice and has not yet been tested among humans. ...
... DC (Thursday, May 22, 2008) For patients undergoing ... lead to an increased risk of diabetes, reports a ... of Nephrology (JASN). , "We demonstrated a robust association ... group of kidney transplant recipients in the United States," ...
... Inc. (Amex:,ADL), ( http://www.amdl.com ), a world ... and Jilin, China, announced today that,it has made ... Q1,2008 financial results conference call. The document can ... . Click on "Investor Relations",then "Recent News.", ...
... 22 The topic of today,s,congressional subcommittee hearing ... importance to Kansas and should serve several,purposes:, ... research,capability to combat the real and present threat ... and agriculture economy., * Demonstrate the urgency ...
... ... difficulties, MINNEAPOLIS, May 22 ... bringing visibility to,dysphagia -- an often undiagnosed, secondary condition resulting from ... makes swallowing extremely difficult and can lead to dangerous,health threats if ...
... involved with learning and memory , , THURSDAY, May 22 (HealthDay ... come with obstructive sleep apnea (OSA), a new study suggests. ... increased oxidative stress that affects brain tissue in areas involved ... study, published in the second issue for May of ...
Cached Medicine News:Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 2Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 3Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 4Health News:Anti-rejection drug may increase risk of diabetes after kidney transplant 2Health News:AMDL Teleconference Available on amdl.com at 5:00 p.m. EDT Today 2Health News:Tip Sheet: Kansas Responds to Congressional Hearing on Animal Disease Research 2Health News:Stroke Victims Often Suffer From Lack of Nutrients With Undiagnosed Disorder 2Health News:Stroke Victims Often Suffer From Lack of Nutrients With Undiagnosed Disorder 3Health News:Green Tea May Help Brain Cope With Sleep Disorders 2
... 50 and 100 ms scans to perform truly ... and proprietary cardiac analysis software take full advantage ... x-ray detector rings to image the lumen of ... wall motion. The EBT C300 also supports traditional ...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right;) overall length 120mm; Stainless ...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right; ) overall length 120mm; Stainless ...
0.12 1x2 tips on a 2.5mm platform; Stainless Steel Tip; 32mm shaft; Titanium Handle....
Medicine Products: